Localisation of mRNA for h5-HT1B and h5-HT1D receptors in human dorsal raphe

被引:12
|
作者
Bidmon, HJ
Schleicher, A
Wicke, K
Gross, G
Zilles, K
机构
[1] Univ Dusseldorf, Dept Neuroanat, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, C & O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany
[3] Knoll AG, Dept Pharmacol, D-67061 Ludwigshafen, Germany
[4] Res Ctr Julich, Inst Med, D-52425 Julich, Germany
关键词
5-HT1B/D serotonin receptors; autoreceptors; heteroreceptors; in situ hybridisation;
D O I
10.1007/s002100000357
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the mammalian mesencephalon, virtually all serotoninergic neurons are located in the raphe nuclei and the adjacent reticular formation. Pharmacological evidence obtained in rodents suggests that terminal and somatodendritic autoreceptors controlling serotonin (5-hydroxytryptamine, 5-HT) release belong to the 5-HT1B/D subtype of receptors, whereas somatodendritic autoreceptors controlling neuronal cell firing are predominantly of the 5-HT1A subtype. This study investigated the presence of h5-HT1D and h5-HT1B receptor mRNA within the subdivisions of the dorsal raphe of post-mortem human brains by means of in situ hybridisation. Although differences in the labelling intensity, which may be caused by different pre- and/or post-mortem conditions, were obvious among the specimens, all brains expressed both the h5-HT1D and the h5-HT1B mRNA in dorsal raphe neurons. In comparison to h5-HT1D mRNA, expression of h5-HT1B mRNA was slightly more abundant. Information on the existence and localisation of h5-HT1D and h5-HT1B receptors in human dorsal raphe neurons confirms that both subtypes may serve an autoreceptor function in humans. This finding is of pharmacological relevance since these receptors are potential new targets for therapeutic interventions in psychiatric disorders such as depression and anxiety.
引用
收藏
页码:364 / 368
页数:5
相关论文
共 50 条